HIV/AIDS Topics England's PrEP Policy in Disarray After National Health Service Turnaround
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 23 March 2016 00:00
- Written by Roger Pebody
Activists, individuals at risk of HIV, and clinicians have reacted with anger to an official U-turn on provision of HIV pre-exposure prophylaxis (PrEP) in England, where National Health Service (NHS) officials have refused to allow a draft policy on PrEP to go forward for further consideration. "By denying full availability of PrEP we are failing those who are at risk of HIV," commented Ian Green of Terrence Higgins Trust, a leading U.K. HIV/AIDS organization. "PrEP has already been approved in the U.S., Kenya, South Africa, Israel, Canada, and France. And yet, our own government refuses to take responsibility for PrEP."
NIAID To Fund Follow-Up Study of Dapivirine Vaginal Ring for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Tuesday, 15 March 2016 00:00
- Written by NIAID
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, will support an open-label continuation study of the dapivirine vaginal ring that demonstrated modest protection against HIV infection, especially among older women, in 2 clinical trials in Africa, as reported at the recent Conference on Retroviruses and Opportunistic Infections in Boston.
CROI 2016: Rapid Rise in PrEP Awareness in U.S. Gay Men, But Only 5% Have Used PrEP
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 14 March 2016 00:00
- Written by Roger Pebody
Large internet surveys of American gay men show that the proportion who have heard of pre-exposure prophylaxis (PrEP) jumped from 45% in 2012 to 68% in 2015, with around half of men willing to consider using PrEP -- but that actual usage is far lower and remains concentrated in a few key urban areas where public health authorities have facilitated its uptake, according to data presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2016)in Boston.
CROI 2016: High STI Rates Among Gay Men on PrEP Supports More Frequent Monitoring
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 14 March 2016 00:00
- Written by Liz Highleyman
Participants taking tenofovir/emtricitabine (Truvada) for pre-exposure prophylaxis (PrEP) continued to have high rates of sexually transmitted infections (STIs) in 2 U.S. PrEP demonstration projects, according to a pair of reports at the Conference on Retroviruses and Opportunistic Infections (CROI 2016)last month in Boston. Semi-annual STI testing missed many cases, leading researchers to suggest that gay men on PrEP could benefit from screening every 3 months.
CROI 2016: Tailored Support Encourages Black Gay Men to Stay on PrEP
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 14 March 2016 00:00
- Written by Liz Highleyman
Providing culturally tailored counseling and support programs for black men who have sex with men can increase their likelihood of maintaining adherence to pre-exposure prophylaxis (PrEP) for HIV prevention, helping to address a key public health gap in the U.S., according to findings from the HPTN 073 study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016)last month in Boston.
More Articles...
- CROI 2016: Maraviroc May Work as PrEP in a Combination, but Probably Not Alone
- CROI 2016: Injection-Related Indiana HIV Epidemic Is Under Control, But Vigilance Needed
- CROI 2016: Studies Look at Condom Use in IPERGAY French PrEP Trial
- CROI 2016: Modest Kidney Function Decline on Truvada PrEP Supports Need for Monitoring
Web Design and Development by